Summary

  • Clearmind has signed to buy newly issued shares representing 51% of Charging Robotics Ltd. for US$2.5 million and to lend the same subsidiary US$1.5 million at closing.
  • The subsidiary—not listed parent Charging Robotics Inc.—would receive both cash streams. The parent would retain 49%, lose control and account for that stake under the equity method.
  • An estimated US$4.865 million unaudited pro forma deconsolidation gain is a valuation and accounting adjustment, not cash paid to the parent or realised operating profit.

Follow the cash past the headline

“US$4 million investment” sounds like one cheque to one company. The filed agreements describe something more exact. On 31 August, Clearmind Medicine agreed to pay US$2.5 million for 149 newly issued ordinary shares of Charging Robotics Ltd., the Israeli operating subsidiary of listed Charging Robotics Inc. At closing, Clearmind is also to provide that subsidiary with a US$1.5 million loan.

Both arrows terminate at the subsidiary. The unaudited pro forma filing states that none of the US$4 million is cash received directly by the listed parent. The equity subscription enlarges the subsidiary’s capital and gives Clearmind 51% on a fully diluted basis. The loan adds liquidity to the same operating company, but also gives Clearmind a creditor claim against it.

That cash-location sentence is the boundary around the transaction. It does not make the deal irrelevant to the parent. The parent would retain 49% of a funded affiliate, recognise balances against a company it no longer consolidates and preserve exposure to later value. But its immediate benefit is not a US$4 million receipt.

The state of the deal matters too. The 4 September Form 8-K says closing was expected during the week of 7 September, subject to payment of the purchase price, funding of the loan and customary conditions. A signed agreement allocates rights and conditions; it does not prove that money has moved or control has changed. Until a closing filing appears, 51% ownership and deconsolidation remain the consequences of a pending close.

The US$2.5m buys control rather than the parent’s shares

Clearmind is not buying 51% of the listed parent. It is subscribing for new shares in Charging Robotics Ltd. at US$16,778 per share. If closing occurs, those 149 shares leave Clearmind with 51% of the subsidiary on a fully diluted basis and the parent with 49%.

The share-purchase agreement says the subsidiary needs substantial additional funds and does not expect revenue in the near future. It identifies repayment of outstanding liabilities—US$3.3 million at 30 June—and ongoing operations as uses for the US$2.5 million of net investment proceeds. It does not prescribe a public dollar-by-dollar allocation between the two.

This is therefore both a financing and a control transaction. New money enters below the public-company level, where the wireless-charging operation sits. In exchange, the listed parent gives up the ability to treat every subsidiary asset, liability, revenue and expense as its own consolidated line.

The product context explains why the capital is going there. Charging Robotics describes systems that transfer energy wirelessly to electric vehicles through resonance coils, aimed particularly at automated parking systems and autonomous platforms. Its 2025 Form 10-K said the subsidiary had initial orders from three automated-parking suppliers. That history supplies commercial context, not evidence that near-term revenue will fund the business; the transaction agreement’s own warning is the more current cash constraint.

The US$1.5m is patient debt, but it remains debt

Clearmind’s second role is lender. Under the loan agreement, the US$1.5 million principal carries simple interest at 4% a year, calculated by actual days over 365. Charging Robotics Ltd. may prepay all or part without penalty or premium.

The stated maturity is three years after funding, but that date contains a capacity test. If the subsidiary’s latest IFRS financial statements do not show sufficient positive cash flow from operating and financing activities, together with available financing sources, to repay principal and accrued interest, maturity extends automatically. Interest continues. Payment becomes due on the first date those sources are sufficient.

That design gives the operating company more time when liquidity is weak; it does not turn the loan into equity. Clearmind retains acceleration rights after specified events, including a payment default that remains uncured for 15 business days, creditor-rescheduling negotiations and certain insolvency, winding-up, receiver or material distress events. The borrower also has rapid notice duties.

The same investor would thus occupy two places in the capital stack: majority shareholder and lender. Equity absorbs business outcomes through ownership value. The loan accrues a contractual return and preserves creditor remedies, even though its repayment clock can extend with the borrower’s capacity.

Deconsolidation creates a gain without creating cash

Loss of control changes how the listed parent reports the subsidiary. Charging Robotics Inc. would remove Charging Robotics Ltd.’s individual assets and liabilities from consolidation, recognise the fair value of its retained 49% interest and then use the equity method for later results.

The filed pro forma balance sheet illustrates that bridge. In US$thousands, it moves the parent from no investment-in-affiliate line to US$2.503 million, from US$8.827 million to US$12.655 million of total assets, from US$4.829 million to US$3 million of total liabilities, and from US$479,000 to US$6.136 million of equity attributable to the company. Cash moves from US$10,000 historically to US$8,000 pro forma—not to US$4.01 million.

The model also estimates a US$4.865 million gain on deconsolidation. That figure can dominate the income statement if read without its mechanics. It is an unaudited adjustment shown as though the transaction had occurred on 1 January 2025 for illustrative purposes. It reflects derecognition and valuation; it is not a cheque from Clearmind, revenue from charging vehicles or realised current-period earnings.

Nor is the US$2.503 million retained-stake value a simple multiplication of Clearmind’s purchase price by 49/51. The filing says its estimate starts with the US$2.5 million paid for 51% and adjusts for a control premium and the benefit of the below-market 4% loan. Those assumptions can move. The final accounting can differ once closing facts and valuations are available.

What stays with the parent

Deconsolidation does not erase economic ties. Balances that were intercompany items inside one group become third-party or related-party balances across the new perimeter. The pro forma balance sheet includes a US$1.494 million loan-to-related-party asset. Future value can reach the parent through its share of subsidiary earnings or losses, dividends or distributions if declared, repayment of balances, or the value of a later exit. None of those is the same as receiving the US$4 million transaction funding.

The parent also does not leave robotics altogether. Before deconsolidation, Charging Robotics Ltd. is to transfer its 18.33% interest in Revoltz Ltd. to the listed parent, so Revoltz remains consolidated there. The transaction narrows and redraws the operating perimeter rather than emptying it.

The precise post-closing governance map remains partly undisclosed. Majority ownership supports the accounting conclusion that Clearmind obtains control, but the filed exhibit does not expose a complete board-composition or reserved-matter schedule. Percentage ownership should not be converted into invented vetoes or board seats.

Sources

  1. Charging Robotics Form 8-K filed 4 September 2026
  2. Share Purchase Agreement, Exhibit 10.1
  3. Loan Agreement, Exhibit 10.2
  4. Unaudited pro forma financial information, Exhibit 99.1
  5. Charging Robotics 2025 Form 10-K
  6. Clearmind Medicine Form 6-K
  7. Clearmind filed announcement, Exhibit 99.1